UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study

BMC infectious diseases, 2024-02, Vol.24 (1), p.251-251

2024

Link zum Volltext

Verfügbarkeit prüfen

A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences

Journal of medical Internet research, 2023-06, Vol.25 (1), p.e38176-e38176

2023

Link zum Volltext

Verfügbarkeit prüfen

Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial

BMC infectious diseases, 2020-12, Vol.20 (1), p.928-11, Article 928

2020

Link zum Volltext

Verfügbarkeit prüfen

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy

BMC infectious diseases, 2018-02, Vol.18 (1), p.74-74, Article 74

2018

Link zum Volltext

Verfügbarkeit prüfen

Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial

Annals of internal medicine, 2019-05, Vol.170 (9), p.594

2019

Link zum Volltext

Verfügbarkeit prüfen

Geographic information system-based screening for TB, HIV, and syphilis (GIS-THIS): a cross-sectional study

PloS one, 2012-10, Vol.7 (10), p.e46029-e46029

2012

Link zum Volltext

Verfügbarkeit prüfen

Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy

Clinical infectious diseases, 2020-06, Vol.70 (12), p.2695-2702

2020

Link zum Volltext

Verfügbarkeit prüfen

High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic

The International journal of drug policy, 2017-09, Vol.47, p.196-201

2017

Link zum Volltext

Verfügbarkeit prüfen

Changes in Health-related Quality of Life for Hepatitis C Virus–Infected People Who Inject Drugs While on Opioid Agonist Treatment Following Sustained Virologic Response

Clinical infectious diseases, 2022-05, Vol.74 (9), p.1586-1593

2022

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus Direct-Acting Antiviral Treatment Adherence Patterns and Sustained Viral Response Among People Who Inject Drugs Treated in Opioid Agonist Therapy Programs

Clinical infectious diseases, 2021-12, Vol.73 (11), p.2093-2100

2021

Link zum Volltext

Verfügbarkeit prüfen

A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection

AIDS and behavior, 2021-05, Vol.25 (5), p.1411-1422

2021

Link zum Volltext

Verfügbarkeit prüfen

More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study

Journal of viral hepatitis, 2023-02, Vol.30 (2), p.172-175

2023

Link zum Volltext

Verfügbarkeit prüfen

Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study

Journal of hepatology, 2024-05, Vol.80 (5), p.702-713

2024

Link zum Volltext

Verfügbarkeit prüfen

Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention

AIDS and behavior, 2021-12, Vol.25 (12), p.3987-3999

2021

Link zum Volltext

Verfügbarkeit prüfen

Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder

Drug and alcohol dependence, 2022-05, Vol.234, p.109403-109403, Article 109403

2022

Link zum Volltext

Verfügbarkeit prüfen

High HCV cure rates among people who inject drugs and have suboptimal adherence: A patient-centered approach to HCV models of care

The International journal of drug policy, 2021-07, Vol.93, p.103135-103135, Article 103135

2021

Link zum Volltext

Verfügbarkeit prüfen

Changes in alcohol use during hepatitis C treatment in persons who inject drugs

Journal of viral hepatitis, 2022-11, Vol.29 (11), p.1004-1014

2022

Link zum Volltext

Verfügbarkeit prüfen

HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy

AIDS care, 2022-10, Vol.34 (10), p.1229-1233

2022

Link zum Volltext

Verfügbarkeit prüfen

Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs

Drug and alcohol dependence, 2023-06, Vol.247, p.109878-109878, Article 109878

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice

Infectious disease clinics of North America, 2018-06, Vol.32 (2), p.347

2018

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs

Clinical infectious diseases, 2020-03, Vol.70 (7), p.1397-1405

2020

Link zum Volltext

Verfügbarkeit prüfen

Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes

Journal of addiction medicine, 2022-07, Vol.16 (4), p.447

2022

Link zum Volltext

Verfügbarkeit prüfen

Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study

The International journal of drug policy, 2024-01, Vol.123, p.104288-104288, Article 104288

2024

Link zum Volltext

Verfügbarkeit prüfen

No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening

Clinical gastroenterology and hepatology, 2016-09, Vol.14 (9), p.1356-1360

2016

Link zum Volltext

Verfügbarkeit prüfen

Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents

Open forum infectious diseases, 2020-10, Vol.7 (10), p.ofaa377-ofaa377

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(48)
Buchkapitel
(1)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(41)
Humans
(32)
Infectious Diseases
(22)
Antiviral Agents - Therapeutic Use
(19)
Hepatitis C
(17)
Hepatitis C - Drug Therapy
(17)
Drug Users
(16)
Hepacivirus
(16)
Female
(15)
Hepatitis C, Chronic - Drug Therapy
(14)
Male
(14)
Substance Abuse, Intravenous - Complications
(13)
Substance Abuse, Intravenous - Drug Therapy
(13)
Hcv
(11)
Hepatitis C - Epidemiology
(11)
Adult
(10)
Drugs
(10)
Hepatitis C Virus
(10)
Substance Abuse
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study

A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences

Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy

Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial

Geographic information system-based screening for TB, HIV, and syphilis (GIS-THIS): a cross-sectional study

Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy

High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic

Changes in Health-related Quality of Life for Hepatitis C Virus–Infected People Who Inject Drugs While on Opioid Agonist Treatment Following Sustained Virologic Response

Hepatitis C Virus Direct-Acting Antiviral Treatment Adherence Patterns and Sustained Viral Response Among People Who Inject Drugs Treated in Opioid Agonist Therapy Programs

A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection

More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study

Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study

Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention

Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder

High HCV cure rates among people who inject drugs and have suboptimal adherence: A patient-centered approach to HCV models of care

Changes in alcohol use during hepatitis C treatment in persons who inject drugs

HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy

Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs

Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice

Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs

Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes

Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study

No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening

Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents

Suchergebnisse filtern